fda approval tirzepatide weight loss approves new weight-loss drug Zepbound (tirzepatide) What Is Tirzepatide Used for?

Long-Term Weight Loss (12 months) After one year of taking the medication, you can expect to lose approximately 15 to 17% of your baseline body weight

You will visit the office twice a month so we can assess your success

Observational data have suggested lower all-cause mortality with GLP-1 RA use compared with other glucose-lowering therapies in advanced CKD ( AKI occurred in four of the seven non-dialysis patients (57.1%)

PLoS ONE 18(1):e0278685 [DOI] [PMC free article] [PubMed] [Google Scholar] 82.Ferhatbegovi L, Mri D, Maci-Dankovi A (2023) The benefits of GLP1 receptors in cardiovascular diseases

Conclusion GLP-1 agonists have revolutionized weight loss with effective, science-backed solutions